
Allena Pharmaceuticals ALNA
Quarterly report 2022-Q2
added 08-15-2022
Allena Pharmaceuticals Total Non Current Liabilities 2011-2026 | ALNA
Annual Total Non Current Liabilities Allena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 10.2 M | 6 M | 10 M | 5.84 M | 106 M | 99.8 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 106 M | 5.84 M | 39.6 M |
Total Non Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
257 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
12.2 M | - | 4.01 % | $ 150 M | ||
|
MorphoSys AG
MOR
|
40.2 M | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
158 M | $ 2.75 | -5.5 % | $ 155 M | ||
|
ARCA biopharma
ABIO
|
409 K | - | 1052.0 % | $ 415 M | ||
|
Albireo Pharma
ALBO
|
79.1 M | - | -0.23 % | $ 916 M | ||
|
ANI Pharmaceuticals
ANIP
|
182 M | $ 81.68 | -0.39 % | $ 1.58 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
4.83 B | - | - | $ 40.3 B | ||
|
Amgen
AMGN
|
37.2 B | $ 341.02 | -0.56 % | $ 183 B | ||
|
Aeglea BioTherapeutics
AGLE
|
4.74 M | - | - | $ 1.01 B | ||
|
Biophytis SA
BPTS
|
2.02 M | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
110 K | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
6.39 M | - | -1.52 % | $ 24.7 M | ||
|
Aytu BioScience
AYTU
|
42.1 M | $ 2.58 | 0.1 % | $ 16.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
73.6 K | $ 3.18 | -2.45 % | $ 7.65 B | ||
|
Akero Therapeutics
AKRO
|
1.52 M | - | - | $ 3.67 B | ||
|
AVROBIO
AVRO
|
276 K | - | 1083.1 % | $ 745 M | ||
|
Aptose Biosciences
APTO
|
10.2 M | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
10.2 M | - | -13.39 % | $ 1.45 M | ||
|
Biogen
BIIB
|
9.03 B | $ 178.15 | 1.15 % | $ 25.9 B | ||
|
Brickell Biotech
BBI
|
146 K | - | -5.38 % | $ 6.06 M | ||
|
Applied Molecular Transport
AMTI
|
106 M | - | - | $ 10.1 M | ||
|
Beam Therapeutics
BEAM
|
26 M | $ 28.26 | -3.52 % | $ 2.33 B | ||
|
Институт стволовых клеток человека
ISKJ
|
541 M | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
101 M | $ 225.58 | 0.73 % | $ 5 B | ||
|
Athira Pharma
ATHA
|
876 K | - | - | $ 269 M | ||
|
Atreca
BCEL
|
12.6 M | - | -11.76 % | $ 5.79 M | ||
|
BioNTech SE
BNTX
|
341 M | $ 114.21 | -2.2 % | $ 27.2 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
686 M | $ 70.17 | 1.52 % | $ 9.39 B | ||
|
CASI Pharmaceuticals
CASI
|
38.2 M | $ 1.0 | 1.5 % | $ 136 M | ||
|
Aeterna Zentaris
AEZS
|
19.1 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
1.53 M | - | -10.17 % | $ 12.2 K | ||
|
Catalyst Biosciences
CBIO
|
981 K | $ 9.97 | -1.77 % | $ 656 M | ||
|
Akouos
AKUS
|
12 M | - | 0.23 % | $ 488 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
48 M | - | -9.72 % | $ 5.89 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
23.6 M | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
22.3 M | - | -7.31 % | $ 87 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.63 M | $ 4.05 | -1.22 % | $ 8.81 B | ||
|
Amneal Pharmaceuticals
AMRX
|
2.42 B | $ 13.87 | -1.74 % | $ 4.29 B | ||
|
AIkido Pharma
AIKI
|
2.29 M | - | 1.93 % | $ 17.4 M | ||
|
Bellerophon Therapeutics
BLPH
|
1.93 M | - | -74.18 % | $ 955 K | ||
|
Cerus Corporation
CERS
|
58.1 M | $ 2.34 | 0.65 % | $ 432 M | ||
|
CureVac N.V.
CVAC
|
112 M | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
244 K | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
15.9 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
5.46 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
3.53 M | - | -11.43 % | $ 502 K | ||
|
Baudax Bio
BXRX
|
65.4 M | - | 0.59 % | $ 63 K |